Pasithea Therapeutics News - KTTA

Company Name	Stock Ticker Symbol	Market	Type
Pasithea Therapeutics Corporation	KTTA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.33	4.88%	7.09	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
6.75	6.71	7.0999	7.09	6.76

more quote information »

Recent News

Date	Time	Source	Heading
3/01/2024	21:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	21:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	21:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	21:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/13/2024	07:59	GLOBE	Pasithea Therapeutics Announces Opening of Enrollment in the..
1/18/2024	16:30	EDGAR2	Form 8-K - Current report
1/08/2024	07:59	GLOBE	Pasithea Therapeutics Announces Invention of Crystalline..
1/02/2024	16:47	EDGAR2	Form 8-K - Current report
1/02/2024	08:35	GLOBE	Pasithea Therapeutics Announces FDA Acceptance of IND..
12/28/2023	17:00	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/28/2023	17:00	GLOBE	Pasithea Therapeutics Announces Adjournment of Reconvened..
12/28/2023	11:30	EDGAR2	Form 8-K - Current report
12/19/2023	17:26	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/19/2023	17:21	EDGAR2	Form 8-K - Current report
12/19/2023	17:19	GLOBE	Pasithea Therapeutics Announces Results from 2023 Annual..
12/11/2023	08:01	GLOBE	Pasithea Therapeutics Announces Positive In Vivo Preclinical..
11/29/2023	17:00	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/29/2023	16:27	GLOBE	Pasithea Therapeutics Announces Adjournment of 2023 Annual..
11/29/2023	07:59	GLOBE	Pasithea Therapeutics Announces Outcome of Pre-IND Meeting..
11/13/2023	16:45	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:59	GLOBE	Pasithea Therapeutics Selects PAS-003 Lead Development..
10/26/2023	17:01	EDGAR2	Form ARS - Annual Report to Security Holders
10/26/2023	17:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
10/16/2023	17:18	EDGAR2	Form PRE 14A - Other preliminary proxy statements
10/13/2023	17:00	EDGAR2	Form 8-K - Current report
9/14/2023	09:15	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
9/14/2023	09:11	EDGAR2	Form 8-K - Current report
9/14/2023	08:30	GLOBE	Pasithea Therapeutics Corp. Announces Final Results of..
9/07/2023	16:14	GLOBE	Pasithea Therapeutics to Participate in H.C. Wainwright 25th..
8/24/2023	17:00	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/21/2023	17:22	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/14/2023	09:02	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
8/11/2023	17:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	09:08	EDGAR2	Form SC TO-I - Tender offer statement by Issuer
8/01/2023	07:59	GLOBE	Pasithea Therapeutics publishes study in Proceedings of the..
7/20/2023	09:03	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
7/20/2023	08:56	EDGAR2	Form 8-K - Current report
7/20/2023	08:43	GLOBE	Pasithea Therapeutics Announces Intention to Commence a..
7/20/2023	08:40	GLOBE	Pasithea Therapeutics Special Committee Rejects Unsolicited..
7/20/2023	08:31	EDGAR2	Form 8-K - Current report
7/03/2023	17:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
6/30/2023	09:28	GLOBE	Pasithea Therapeutics Confirms Previous Creation of..
6/29/2023	14:50	GLOBE	Lucy Scientific Discovery Reiterates Its Proposal to Acquire..
6/29/2023	08:29	GLOBE	Pasithea Therapeutics Announces Completion of GMP..
6/06/2023	16:30	GLOBE	Pasithea Therapeutics Confirms Receipt of Unsolicited..
6/05/2023	09:00	GLOBE	Lucy Scientific Discovery Announces Proposal to Acquire..
6/01/2023	07:57	GLOBE	Pasithea Therapeutics Abstract Accepted for Poster..
5/03/2023	08:26	GLOBE	Pasithea Therapeutics to Participate in EF Hutton Inaugural..